Zur Kurzanzeige

dc.contributor.authorEsquinas, Cristina
dc.contributor.authorRamon, Maria A.
dc.contributor.authorNuñez, Alexa
dc.contributor.authorMolina, Jesús
dc.contributor.authorQuintano, José A.
dc.contributor.authorRoman-Rodríguez, Miguel
dc.contributor.authorNaberan, Karlos
dc.contributor.authorLlor, Carl
dc.contributor.authorRoncero Alonso, Carlos 
dc.contributor.authorMiravitlles, Marc
dc.contributor.authorBarrecheguren, Miriam
dc.date.accessioned2025-01-29T11:38:51Z
dc.date.available2025-01-29T11:38:51Z
dc.date.issued2020
dc.identifier.citationEsquinas, C., Ramon, M. A., Nuñez, A., Molina, J., Quintano, J. A., Roman-Rodríguez, M., ... & Barrecheguren, M. (2020). Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Quality of Life Research, 29, 607-617.es_ES
dc.identifier.issn1573-2649
dc.identifier.issn0962-9343
dc.identifier.urihttp://hdl.handle.net/10366/163078
dc.description.abstract[EN]Purpose: Impaired health-related quality of life (HRQoL) is associated with poor health outcomes in chronic obstructive pulmonary disease (COPD). The aim of this study was to determine health utilities in patients with COPD and to identify the variables with the greatest impact. Methods: This is a pooled analysis of data from 4 observational studies performed in stable COPD patients. Evaluation of patient HRQoL utilities was performed using the Spanish version of the self-administered EuroQoL 5 Dimensions (EQ-5D) questionnaire. EQ-5D utilities were described and compared according to several markers of disease severity. Results: 6198 patients reported a mean (SD) EQ-5D index of 0.67 (0.26). A linear dose response relationship between EQ-5D utility and modified Medical Research Council (mMRC) score, forced expiratory volume in one 1 s (% predicted), COPD hospital admissions in the previous year, self-reported daily walking time, Charlson index, body mass index, obstruction, dyspnoea and exacerbation (BODEx) index, COPD assessment test (CAT), hospital anxiety and depression scale was observed (p for trend < 0.001). In multivariate analysis, patients reporting lower utility values were those with more dyspnoea, more comorbidities, using long-term oxygen therapy, with previous hospitalisations due to a COPD exacerbation and higher (worse) CAT score. Conclusion: HRQoL measures such as EQ-5D can assist clinicians to understand the impact of respiratory disease on COPD patients.es_ES
dc.language.isoenges_ES
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.subjectQuality of lifees_ES
dc.subjectCopdes_ES
dc.subjectEQ-5Des_ES
dc.subjectHealth-Related Quality of Life.es_ES
dc.titleCorrelation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/ 10.1007/S11136-019-02340-4es_ES
dc.subject.unescoquality of life, COPDes_ES
dc.identifier.doi10.1007/S11136-019-02340-4
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid31673922
dc.journal.titleQuality of Life Researches_ES
dc.volume.number29es_ES
dc.issue.number3es_ES
dc.page.initial607es_ES
dc.page.final617es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

CC0 1.0 Universal
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: CC0 1.0 Universal